ArticlePloS one2016

The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features.

Lu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.